Digital pain care, elbow strength, wound healing and the tradeoffs in carpal-tunnel testing—with two product recalls to check now.
Radu Physiatry editorial desk · About 12 minutes · AI-assisted, source-checked; not physician-reviewed
A rehabilitation tool earns its place by answering a specific question. Can someone use the hand more effectively? Is a wound closing? Does a test clarify the cause of numbness? A glowing screen, a comfortable device or a larger muscle measurement cannot answer all three. Today's studies show why the outcome needs to be named before the technology is chosen.
A large review examines digital care for chronic musculoskeletal pain. Two randomized trials separate elbow strength from pain relief and wound-device satisfaction from healing. A diagnostic study in wheelchair users with spinal cord injury shows how changing an ultrasound threshold changes the mistakes a test makes. These are different research questions, with different kinds of uncertainty.
We begin with two product recalls posted by FDA on October 7. The research below was published October 6–8; the 2024 guideline is explicitly established teaching. The study question turns sensitivity into a concrete counting problem. No physician review has been recorded for this edition.
Product safety · Company announcements October 6; FDA postings October 7, 2026
Before the workout, check the container
Leader Formulas recalls RAPTURE Preworkout, lot 260327-4, because it contains DMAA, or 1,3-dimethylamylamine. The notice identifies 450-gram containers in Rainbow Twist, Electric Lemonade and Berry Mojito flavours. DMAA can increase blood pressure and cause cardiovascular problems. No adverse events were reported in the announcement; that does not establish safety or tell us how many users were exposed.
The recall directs people to stop using the affected product and return it for a refund. Read the actual notice against the container. A product marketed for exercise is not evidence that it belongs in a rehabilitation programme; a safety notice is not a trial of exercise performance.
Pacific Health Sciences recalls Babies Magic Tea Baby Sleep Gripe Water, lot 25122bw, best before 12/2028. FDA testing found unlisted ethanol (8.3%), methanol (0.35%) and isopropanol (0.48%). The notice says to stop using this lot and discard it or return it for a refund; seek medical care if symptoms develop. No adverse events were reported. This concerns the identified liquid product, not every tea or gripe-water product.
Chronic musculoskeletal pain · Systematic review and network meta-analysis · Main full article reviewed · Published October 7, 2026
Ask what the app delivers
A review of 92 randomized trials, involving 12,595 adults, grouped digital interventions by both platform and therapeutic content. Its search ended January 29, 2026. In the network analysis, app-delivered exercise versus the combined control category had a pain effect of SMD −0.23, 95% credible interval −0.42 to −0.04, and disability effect of −0.33, −0.59 to −0.08. Both estimates had low-certainty evidence.
These are standardized differences, not points on a ten-point pain scale. For a patient considering digital care, useful questions are what activities it supports, who adapts them, and which real-life goal will be monitored.
Clinical notes: average benefit, prediction and ranking
The network combined active and inactive comparators into one control node. Across the review, evidence certainty was low or very low. Pairwise prediction intervals crossed zero for many comparisons; treatment rankings remained uncertain. Variable interventions, self-reported outcomes and limited direct comparisons restrict interpretation.
A credible interval describes uncertainty about the estimated effect under the model. A prediction interval addresses variation expected across settings; the two intervals answer different questions. A favourable average cannot guarantee benefit in the next clinic. Likewise, a high rank cannot establish clinical superiority. The main article was appraised; its supplements and underlying trials were not independently reviewed.
Musculoskeletal rehabilitation · Single-blind randomized trial · Abstract only · Published October 7, 2026
A stronger grip does not settle the pain question
Fifty-two people with lateral epicondylitis, commonly called tennis elbow, were randomized to conventional physiotherapy or the same programme plus low-load blood flow restriction training. Both groups attended twelve sessions over six weeks. Blood flow restriction combines exercise with controlled limb compression; the trial's exact pressure and application protocol were not available for appraisal.
Handgrip strength was the primary outcome. Mean increases were 17.50 pounds with conventional therapy and 35.54 pounds with the added training. The post-treatment comparison favoured the combined programme (P < .001). The Patient-Rated Tennis Elbow Evaluation score also favoured it, but the abstract supplies no absolute scale difference or confidence interval for that result.
There was no statistically significant added benefit for pain at rest, pain during activity or treatment satisfaction. That finding changes the conversation. If the priority is gripping an object, a strength signal may matter. If the priority is pain relief, this report does not demonstrate that the added intervention improves that outcome beyond conventional therapy.
Clinical notes: distinguish the change score from the comparison
The authors report a rank-biserial correlation of 0.911, 95% CI 0.800–0.984, for the post-treatment strength comparison. This rank-based effect is not a 91.1% improvement and is not a confidence interval around the difference between the two mean gains. The abstract's “±” values are not clearly identified as standard deviations or standard errors, so they are not relabelled here.
Within-group improvements cannot establish the added treatment's causal benefit: the randomized comparison between groups is the relevant test. Conversely, a nonsignificant pain comparison does not prove equivalence. Precision, the prespecified analysis and a clinically meaningful margin would be needed to support that claim.
Six-week reassessment supplies short-term evidence. Longer-term function, recurrence, pressure selection, screening exclusions and complete adverse-event accounting remain unverified because the full article was inaccessible after retries. This article supplies no self-treatment cuff protocol. The clinical decision would need an appropriate assessment and a reproducible supervised technique, rather than extrapolation from a trial label.
Rehabilitation complications · Multicentre pragmatic randomized trial · Abstract only · Published October 7, 2026
A well-liked device still has to improve the outcome
The IPCOTT trial enrolled 136 adults with hard-to-heal venous or mixed venous–arterial leg ulcers who were already receiving compression. Sixty-five received an additional thigh pneumatic-compression device for two hours daily; seventy-one continued standard care alone. The study lasted sixteen weeks, and 116 participants completed it.
The primary outcome, median wound-area reduction, was 64.0% with the added device versus 67.7% with standard care (P = .35). Complete healing occurred in 16.9% versus 18.3% (P = .80). Pain and quality-of-life findings likewise showed no between-group advantage. Meanwhile, 64% rated the device very good or excellent.
Those answers can coexist. Comfort and acceptability may make a tool easier to use without making a wound heal faster. The relevant comparison was additional treatment on top of existing care. This report does not suggest abandoning standard compression, and it does not establish that every lower-limb wound is suitable for the same treatment.
Clinical notes: a negative primary outcome and incomplete precision
Percentage wound-area reduction and complete closure are different endpoints. A smaller wound is not necessarily a healed wound. Patient satisfaction is another outcome again; it cannot rescue a negative healing comparison.
Adverse events were reported in 54% of the device group and 59% of controls, mainly mild, with one mild device-related event. That is a tolerability observation within this study, not proof of safety for every patient. A clinician still needs to assess the wound's cause and the person's vascular condition before applying a treatment.
The trial was open-label. Twenty participants did not complete it; the abstract does not provide confidence intervals, complete missing-data methods or enough detail to verify how all randomized participants entered the analysis. A nonsignificant result does not prove exact equality or rule out every smaller effect. The justified statement is that this trial did not demonstrate added healing benefit in its studied population. Full-text access remained unavailable after retries.
Spinal cord injury and electrodiagnosis · Prospective cross-sectional diagnostic study · Abstract only · Published October 8, 2026
The ultrasound threshold chooses a tradeoff
A Thai university rehabilitation study evaluated ultrasound measurement of the median nerve in 67 wheelchair users with spinal cord injury. Examiners were blinded. Electrodiagnostic testing served as the reference against which ultrasound was compared. Twenty-five people had carpal tunnel syndrome; among 126 wrists, 42 had electrodiagnostically confirmed disease. People and wrists are different denominators.
The overall area under the receiver-operating-characteristic curve was 0.76, 95% CI 0.67–0.84, indicating moderate discrimination. At a nerve-area cutoff of 10 mm², sensitivity was 90.5% and specificity 45.2%. Raising the cutoff to 15 mm² changed those figures to 33.3% and 91.7%.
The lower threshold caught more affected wrists but also labelled more unaffected wrists positive. The higher threshold reduced false positives while missing many affected wrists. A scan number therefore needs a clinical question attached: is the purpose to avoid missing a condition, or to obtain stronger confirmation? Neither threshold answers every diagnostic problem.
Clinical notes: sensitivity is not the probability after a positive test
Sensitivity starts with wrists that have the condition according to the reference test and asks how many ultrasound identifies. Specificity starts with reference-negative wrists. The probability of disease after a positive ultrasound is a different quantity, the positive predictive value, which also depends on how common disease is in the tested population.
An AUC of 0.76 is not “76% of patients correctly diagnosed.” It summarizes discrimination across thresholds. The two operating points show why a single AUC cannot choose a threshold for a particular purpose.
This is one specialist setting, not external validation. The abstract does not supply cutoff-specific confidence intervals or explain adjustment for two wrists from the same person; 126 wrists should not automatically be treated as 126 independent people. The publisher page and attempted full-text route supplied the abstract and a machine-generated summary, which was excluded. No trial here tested whether ultrasound-guided decisions improve hand function.
Established guidance · AAOS carpal tunnel guideline · Published and adopted May 18, 2024
Start with the clinical assessment
The AAOS guideline gives a strong recommendation, supported by high-quality evidence, that the CTS-6 clinical tool can be used to diagnose carpal tunnel syndrome instead of routine ultrasound or nerve-conduction/electromyographic testing. Its scope is adults presenting with complaints that may be attributable to carpal tunnel syndrome. The diagnostic rationale discusses additional testing when the clinical assessment is less convincing; it does not identify one tool as universally superior.
This is older teaching, not a new October 8 recommendation. It also does not establish the validity of today's ultrasound cutoffs for every wheelchair user or every complex neurological presentation. A useful clinical question is what uncertainty remains after the history and examination, and whether another test will resolve it. We read the actual diagnostic recommendation and rationale, along with the guideline's scope; its other treatment recommendations and evidence appendices were not appraised for this edition.
Patient communication and cancer rehabilitation education · Scoping review with expert refinement · Abstract only · Published October 6, 2026
A useful exercise visit begins with questions
A breast-cancer survivorship study used 29 studies about exercise and communication preferences to draft a question prompt list, then refined it through interviews with ten experts. This is development work, not a randomized test of whether the list increases exercise participation. The full prompt list was unavailable, so we do not reproduce it or claim to have evaluated its individual questions.
The learning opportunity is to turn a broad recommendation into a conversation. Our own suggested questions are: Which activities fit my current treatment and limitations? What change should we monitor? When should the plan be adjusted? These are editorial examples, not quotations from the study or a validated questionnaire.
Reported preferences describe what respondents wanted; they do not establish an effective or safe dose for every survivor. Expert agreement cannot substitute for testing the list with patients and measuring its effects. For a trainee, explaining that distinction is part of learning rehabilitation. The magazine provides independent education and an original practice question, without accredited CME or official examination credit.
In the cited spinal cord injury study, the 15 mm² ultrasound cutoff had 33.3% sensitivity. For an illustrative group of 100 wrists already known to have carpal tunnel syndrome by the reference test, approximately how many would this sensitivity imply are missed?
Eight, because specificity is 91.7%.
Thirty-three, because sensitivity is 33.3%.
Sixty-seven, because the false-negative proportion is about 66.7%.
None, because a positive ultrasound proves the diagnosis.
Reveal answer and explanation
C. Sensitivity of 33.3% means about 33 of 100 reference-positive wrists would test positive; about 67 would be missed. This is an illustrative calculation, not an additional observed cohort. Specificity uses reference-negative wrists and cannot answer this question. The probability of disease after a positive result needs separate information. This original educational item is based on the cited study, not an official board question.
The small glossary
PM&R
Physical medicine and rehabilitation: care that addresses function, activity and participation alongside the health condition.
Standardized mean difference (SMD)
A difference expressed in standard-deviation units so studies using different scales can be combined. It is not a raw pain-score change.
Credible interval
A Bayesian model's interval for an estimated effect, conditional on its assumptions and data.
Prediction interval
An interval describing variation expected for an effect in a further comparable setting, rather than uncertainty only about the average.
Network meta-analysis
A synthesis combining direct and indirect treatment comparisons; differences between studies can weaken those comparisons.
Pragmatic trial
A trial designed to evaluate treatment under conditions closer to ordinary care.
Electrodiagnosis
Testing nerve and muscle electrical function; nerve-conduction studies and electromyography answer related but distinct questions.
Sensitivity / specificity
The fractions correctly identified among reference-positive and reference-negative cases, respectively.
Positive predictive value
The fraction of positive tests that correspond to disease in the population tested.
Cross-sectional study
A study assessing measurements at a particular time; it does not by itself establish what causes later outcomes.
The practical takeaway: name the goal before choosing the tool, then ask whether the evidence measures that goal. Strength, comfort, healing and diagnostic confirmation need their own outcomes. Check the comparator and uncertainty, keep product-specific recall instructions current, and use the evidence to inform an individual clinical conversation.
Four clinical reports and one patient-communication development study were appraised: a systematic review/network meta-analysis, two randomized trials, a cross-sectional diagnostic study, and a scoping review with expert refinement. The main digital-pain article and its Table 1 were read through verified web access; its supplements and underlying trials were not independently appraised. The other four reports were reviewed through their primary abstracts; publisher retries did not provide full text, and the diagnostic publisher automated summary was excluded. Actual FDA-posted RAPTURE and Babies Magic Tea recall announcements, and the AAOS 2024 carpal-tunnel guideline scope, diagnostic recommendation and rationale, were separately read. Other guideline recommendations and evidence appendices were not appraised. Licensed chapters, paid education and source transcripts were unavailable or not appraised. No physician review has been recorded. This is independent education, not accredited CME or official examination material.
The discovery window was 2026/09/08–2026/10/08. A journal index check can miss work not yet indexed. A retrieved landing page does not verify every linked publication, paid course, podcast or textbook chapter. Candidate counts are discovery records, not validated practice changes.
Educational, not medical advice. Discuss treatment choices with your clinician. Sources and evidence evolve; each dated edition preserves what was checked for that issue.